HMGB1 and cancer: Using K562-differentiated megakaryocytes and murine platelets, conditioned medium and exosomes obtained from megakaryocytes and platelets contained HMGB1 and promoted cancer cell survival, as well as protected cancer cells from doxorubicin cytotoxicity.